Menu Search
Equities

Dr Hoenle AG

HNL:FRA

Dr Hoenle AG

Actions
  • Price (EUR)8.70
  • Today's Change-0.34 / -3.76%
  • Shares traded500.00
  • 1 Year change-52.33%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dr Hoenle AG is a Germany-based company engaged in the basic materials and industrials sectors. The Company develops, manufactures and supplies ultraviolet (UV) equipment. The Company operates three business segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment encompasses the development, production and sale of UV equipment and systems used for drying inks and coatings, for curing adhesives and plastics, disinfecting surfaces and for sunlight simulation. The Adhesives segment comprises the development, production and sale of UV industrial adhesives for the use in the automotive, electronics, medical technology and optics industries, among others. The Glass and Lamps segment includes the development, production and sale of tubing and semi-finished goods made from quartz glass as well as the manufacture of UV medium-pressure and low-pressure lamps. The Company is globally active, with over 69 locations in 27 countries.

  • Revenue in EUR (TTM)98.66m
  • Net income in EUR-5.37m
  • Incorporated1999
  • Employees573.00
  • Location
    Dr Hoenle AGNicolaus-Otto-Str. 2GILCHING 82205GermanyDEU
  • Phone+49 810520830
  • Fax+49 81 052083148
  • Websitehttps://www.hoenle.de/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.